← Eichor
Study identifier: NCT07345923 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

Condition: Infections, Enterobacteriaceae  ·  Sponsor: University Hospital, Strasbourg, France

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objective of the research is to evaluate the value of testing for ESBL carriage by rectal swab to predict the risk of ESBL-producing Enterobacteriaceae infections in intensive care.

This description comes directly from the study's public registry record.

Talk to the study team

baptiste Hoellinger, MD  ·  33 3 69 55 05 45  ·  baptiste.hoellinger@chru-strasbourg.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - FranceStrasbourg, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07345923